Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02234622 · ClinicalTrials.gov registry record · NA
Comparing Effects of a Holistic Yoga Program and a Wellness Program on PTSD Symptoms
A NA study of Stress Disorders, Post-Traumatic, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 212
- Enrollment target
- 1
- Study location
NCT02234622: Completed NA study of Stress Disorders, Post-Traumatic, sponsored by VA Office of Research and Development.
NCT02234622 is a NA study of Stress Disorders, Post-Traumatic that has completed, run by VA Office of Research and Development. The registered enrollment target is 212 participants, above the 153-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (39% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02234622, a NA study of Stress Disorders, Post-Traumatic, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
- 1
- Study location
Study Summary
Given the limited effectiveness of current treatments and the burden PTSD places on Veterans, civilians and clinicians, this research aims to compare the effects of a standardized, traditional, holistic yoga intervention (postures, breathing, deep muscle contraction and relaxation practices) with a wellness program (wellness topics and physical activity) on PTSD symptoms.
Primary Outcome
The CAPS is a semi-structured clinician administered interview that measures PTSD diagnostic status and symptom severity consistent with the Diagnostic and Statistical Manual-Fifth Edition. Scores range 0-80 with higher scores meaning a worse outcome.
Conditions Studied
Interventions
- BEHAVIORAL Holistic Yoga Program
- BEHAVIORAL Wellness Lifestyle Program
Study Locations (1)
Indiana
- Richard L. Roudebush VA Medical Center, Indianapolis, IN - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2015-08-03 |
| Est. Completion | 2018-08-09 |
| Phase | NA |
What the finished NCT02234622 record still lists
NCT02234622 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, above the 153-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (39% higher).
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Holistic Yoga Program is the first listed.
NCT02234622 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT02234622 about?
NCT02234622 is a clinical study titled "Comparing Effects of a Holistic Yoga Program and a Wellness Program on PTSD Symptoms". Given the limited effectiveness of current treatments and the burden PTSD places on Veterans, civilians and clinicians, this research aims to compare the effects of a standardized, traditional, holistic yoga intervention (postures, breathing, deep muscle contraction and relaxation practices) with a ...
What is the current status of trial NCT02234622?
This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2015-08-03. Estimated completion is 2018-08-09.
What conditions does trial NCT02234622 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT02234622?
The interventions under investigation include: Holistic Yoga Program (BEHAVIORAL), Wellness Lifestyle Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02234622?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02234622 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02234622's enrollment target sits among peer trials
212 12th of 66 higher than 55 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI